SELLAS Life Sciences Group Inc

NASDAQ:SLS   12:50:14 PM EDT
7.05
+0.05 (+0.71%)
Earnings Announcements

Sellas Life Sciences Reports Q3 Loss Per Share Of $0.45

Published: 11/12/2021 14:02 GMT
SELLAS Life Sciences Group Inc (SLS) - Sellas Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update.
Q3 Loss per Share $0.45.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.42

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.